Preserving donor livers with eXVIVO before transplant
Part of Digestive system clinical trials.
This trial tests a new way to preserve donated livers with a machine called eXVIVO before transplant. It is for adults receiving their first liver transplant and aims to see if this preservation method improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be listed for your first liver transplant on the UNOS waiting list.
- If you have liver cancer (HCC), the tumor must meet Milan criteria or be reduced to that size before transplant.
- You cannot need a ventilator or heart support machines.
- You cannot be pregnant or receiving other organ transplants at the same time.
- You cannot be in another trial with an experimental drug or device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people do in the long run after liver transplant using donor livers that were preserved in a specific machine called DHOPE for more than 4 hours. It may help doctors understand whether this preservation method leads to better transplant outcomes over time.
This study tests a special way of preserving donated livers, called HOPE, to see if it lowers the chance of liver cancer coming back after a liver transplant. If you have liver cancer and are waiting for a transplant, this trial might be an option for you.
This study tests a new way to preserve donated livers (called machine perfusion) after they are recovered from donors who died from circulatory causes. It aims to see if this method helps the liver work better before transplant.
This study collects information about how livers do after transplantation when they've been preserved using machine perfusion—a technique that keeps donor livers in better condition before surgery. Researchers want to understand which preservation methods work best to improve transplant success across Europe.
This trial tests whether adding a hormone called secretin to a machine that preserves donated livers outside the body can improve liver quality and transplant outcomes. You may qualify if you're an adult receiving a standard deceased-donor liver transplant that needs special preservation techniques.
This trial tests whether using a machine to keep donated livers healthy (normothermic machine perfusion) can allow more people to receive a transplant sooner. It is for patients who are already on the waiting list for a liver and have a moderately severe MELD score (25 or less).
Hear when a new Liver Transplant Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.